Isorhamnetin: A review of pharmacological effects.
Study Design
- 研究类型
- Review
- 研究人群
- None
- 干预措施
- Isorhamnetin: A review of pharmacological effects. None
- 对照组
- None
- 主要结局
- None
- 效应方向
- Positive
- 偏倚风险
- Unclear
Abstract
Isorhamnetin is one of the most important active ingredients in the fruits of Hippophae rhamnoides L. and the leaves of Ginkgo biloba L., which possesses extensive pharmacological activities. At present, there have been numerous investigations on isorhamnetin, which has the effects of cardiovascular and cerebrovascular protection, anti-tumor, anti-inflammatory, anti-oxidation, organ protection, prevention of obesity, etc. The related mechanisms involve the regulation of PI3K/AKT/PKB, NF-κB, MAPK and other signaling pathways as well as the expression of related cytokines and kinases. Isorhamnetin has a high value of development and application. However, the investigations on its mechanism of action are limited and lack of detailed scientific validation. The manuscript reviewed the pharmacological effects of isorhamnetin and related mechanisms of action for the development of its medicinal properties further.
简要概述
The manuscript reviewed the pharmacological effects of isorhamnetin and related mechanisms of action for the development of its medicinal properties further and highlighted the need for detailed scientific validation on its mechanism of action.
Used In Evidence Reviews
Similar Papers
Archives of physical medicine and rehabilitation · 2000
Ginkgo biloba extract: mechanisms and clinical indications.
The Cochrane database of systematic reviews · 2007
Ginkgo biloba for cognitive impairment and dementia.
JAMA · 2009
Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.
The Cochrane database of systematic reviews · 2009
Ginkgo biloba for cognitive impairment and dementia.
Clinical pharmacokinetics · 2013
Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2015